Keyword: Giovanni Caforio
Pharma came storming out of the gate at this year's J.P. Morgan meeting in a Monday full of deal talk, CEO ambitions and analyst prognostications.
On Bristol-Myers Squibb’s Thursday third-quarter conference call, executives plunged right into investors' doubts.
Following a big finish in the fourth quarter, Bristol-Myers' CEO took home a 10% pay raise for 2017 to $18.7 million.
There's "still significant growth ahead” for next-gen anticoagulant Eliquis, the way Bristol-Myers Squibb CEO Giovanni Caforio sees it.